At GSK, we have an important role to play in improving the quality of human life by enabling people to do more, feel better and live longer. We work to develop and expand access to medicines and products that help millions of people around the world, regardless of where they live, or their ability to pay.
We are committed to developing our business in a way that takes into account social, economic and environmental considerations; and striving to create a world that is fair, equitable and inclusive for future generations.
In the UN’s Global Goals for Sustainable Development (SDGs) health is explicitly included in goal number 3 – “ensure healthy lives and promote wellbeing for all at all ages.” We will support this by tackling some of the biggest global health challenges – from newborn mortality to malaria.
You will find below a snapshot of some of the health-related examples of our contributions to this agenda.
To read more about our commitment to the please download our commitment to Sustainable Development factsheet (PDF).
Eradicate extreme poverty and hunger
By supplying medicines and vaccines, we’re helping to fight diseases, such as polio and lymphatic filariasis, that can leave people unable to support themselves and their family.
Life after polio: Fatihas story
Achieve universal primary education
Treating children for diseases such as intestinal worms can improve their chances of attending school. We have pledged to donate up to 400 million treatments to enable the deworming of school-age children to the World Health Organization each year to 2020.
Video: Controlling worms, investing in the future
Promote gender equality and empower women
We have a range of community programmes that help women such as supporting the training of health workers. We also support development organisation Pro Mujer which helps women in Latin America to overcome poverty by providing financial services, healthcare and education.
Reduce child mortality
Over 80% of the 883 million doses of vaccines we delivered in 2012 went to developing countries. As part of that, we are increasing access to newer vaccines for pneumococcal disease and rotavirus through our partnership with the GAVI Alliance.
GSK and the Decade of Vaccines report
Improve maternal health
We reinvest 20% of any profits we make in Least Developed Countries back into those countries’ healthcare infrastructure. For
example, in Bangladesh we are working with CARE International to train birth attendants and health providers, and aim to reach over 410,000 women in three years.
How we invest in Least Developed Countries
Combat HIV/AIDs, malaria and other diseases
The biggest contribution we can make is through innovation. We have invested $300m so far to develop our malaria vaccine candidate in partnership with the PATH Malaria Vaccine Initiative and have a long history of researching medicines to fight HIV.
Find out more about our work on HIV
Our commitment to fighting malaria
Ensure environmental stability
We have set ambitious goals to reduce carbon, water and waste from the sourcing of raw materials and the impacts of our own labs and factories, to the use and disposal of our products by patients and consumers.
Develop a global partnership for development
Partnerships are fundamental to the way we operate. In 2013, we formed an innovative partnership with Save the Children where we will work together to help save the lives of one million children.
More on our Save the Children partnership
Find out more about us
Our forward-looking commitments aim to address global health needs and are aligned with our values
Health for all
Our part in tackling global health challenges and our aim to extend the benefits of our products to more people
We are changing the way we work to further embed our values in everything we do, including the way we research, develop, sell and market our products
Learn how we create an inspiring and supportive work environment that encourages employees to develop capabilities and achieve their best